LA Times - "Take Those Medical Journal Pharmaceutical Ads With Grain Of Salt"
Most pharmaceutical ads in biomedical journals may not be up to snuff as far as Food and Drug Administration guidelines are concerned, a study finds. Only about 18 percent of the ads complied with all 20 FDA guidelines and about 58 percent didn't calculate serious risks of the drugs, including death. Lead author Dr. Deborah Korenstein of Mount Sinai School of Medicine said, “We are hopeful that an update in FDA regulations, with increased emphasis on the transparent presentation of basic safety and efficacy information, might improve the quality of information provided in physician-directed pharmaceutical advertisements." Learn more.